SI-BONEreported 2Q20 orthopedic revenue of USD $14 million, -13.9% vs. 2Q19. The company bounced back from -85% revenue declines in April to +6% in May and then +42% in June. However, leadership expects a majority of its case backlog was exhausted in that period. June revenues were down -10% when excluding cases rescheduled from March and April. SI-BONE expects sequential improvement throughout 2020, but at slower rates than observed in the second quarter.
The company continued to expand its insured patient base through the quarter, adding 23.1 million covered lives through Aetna and CareSource. These coverage wins generally take about six months to translate into new cases as patients go through the conservative portions of the treatment algorithm. Additionally, SI-BONE signed a purchasing agreement with Surgical Care Affiliates, a network of 210 ASCs in 35 states. Half of those centers have neurosurgical and spine capabilities, and the deal offers centers a choice to obtain preferred pricing by using iFuse exclusively.
Revenue Data
All revenue data is provided in USD millions unless otherwise noted. Sales and growth rates are estimated on an as-reported basis.
Segment Sales
2Q20
2Q19
$ Chg
% Chg
Spine
$14.0
$16.3
($2.3)
(13.9%)
1H20
1H19
$ Chg
% Chg
Spine
$30.9
$31.3
($0.4)
(1.4%)
Geographic Sales
2Q20
2Q19
$ Chg
% Chg
US
$13.2
$15.0
($1.8)
(12%)
OUS
$0.8
$1.3
($0.5)
(36.2%)
Total
$14.0
$16.3
($2.3)
(13.9%)
1H20
1H19
$ Chg
% Chg
US
$28.5
$28.5
$0.0
0.2%
OUS
$2.4
$2.8
($0.5)
(17.2%)
Total
$30.9
$31.3
($0.4)
(1.4%)
Earnings
Amt
% of Sales
Sales
$14.0
Cost of Sales
$2.1
15.1%
General and Admin
$5.4
38.4%
Sales and Marketing
$19.3
137.2%
R & D
$2.2
15.4%
Other
$2.3
16.6%
Net Earnings
($12.5)
(88.8%)
Mike Evers is ORTHOWORLD’s Digital Content Strategist. He can be reached by email.
SI-BONEreported 2Q20 orthopedic revenue of USD $14 million, -13.9% vs. 2Q19. The company bounced back from -85% revenue declines in April to +6% in May and then +42% in June. However, leadership expects a majority of its case backlog was exhausted in that period. June revenues were down -10% when excluding cases rescheduled from March...
SI-BONEreported 2Q20 orthopedic revenue of USD $14 million, -13.9% vs. 2Q19. The company bounced back from -85% revenue declines in April to +6% in May and then +42% in June. However, leadership expects a majority of its case backlog was exhausted in that period. June revenues were down -10% when excluding cases rescheduled from March and April. SI-BONE expects sequential improvement throughout 2020, but at slower rates than observed in the second quarter.
The company continued to expand its insured patient base through the quarter, adding 23.1 million covered lives through Aetna and CareSource. These coverage wins generally take about six months to translate into new cases as patients go through the conservative portions of the treatment algorithm. Additionally, SI-BONE signed a purchasing agreement with Surgical Care Affiliates, a network of 210 ASCs in 35 states. Half of those centers have neurosurgical and spine capabilities, and the deal offers centers a choice to obtain preferred pricing by using iFuse exclusively.
Revenue Data
All revenue data is provided in USD millions unless otherwise noted. Sales and growth rates are estimated on an as-reported basis.
Segment Sales
2Q20
2Q19
$ Chg
% Chg
Spine
$14.0
$16.3
($2.3)
(13.9%)
1H20
1H19
$ Chg
% Chg
Spine
$30.9
$31.3
($0.4)
(1.4%)
Geographic Sales
2Q20
2Q19
$ Chg
% Chg
US
$13.2
$15.0
($1.8)
(12%)
OUS
$0.8
$1.3
($0.5)
(36.2%)
Total
$14.0
$16.3
($2.3)
(13.9%)
1H20
1H19
$ Chg
% Chg
US
$28.5
$28.5
$0.0
0.2%
OUS
$2.4
$2.8
($0.5)
(17.2%)
Total
$30.9
$31.3
($0.4)
(1.4%)
Earnings
Amt
% of Sales
Sales
$14.0
Cost of Sales
$2.1
15.1%
General and Admin
$5.4
38.4%
Sales and Marketing
$19.3
137.2%
R & D
$2.2
15.4%
Other
$2.3
16.6%
Net Earnings
($12.5)
(88.8%)
Mike Evers is ORTHOWORLD’s Digital Content Strategist. He can be reached by email.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.
Copy to clipboard 
